NCT05720364View on ClinicalTrials.gov

Study to Evaluate the Food Effect of TP-05 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

January 19, 2023

Primary Completion Date

May 30, 2023

Study Completion Date

May 30, 2023

Conditions

Healthy

Interventions

DRUG

TP-05 (lotilaner oral), fasted group

TP-05 (lotilaner oral), fasted group

DRUG

TP-05 (lotilaner oral), high-fat group

TP-05 (lotilaner oral), high-fat group

DRUG

TP-05 (lotilaner oral), low-fat group

TP-05 (lotilaner oral), low-fat group

Trial Locations (1)

66212

Dr. Vince Clinical Research, Overland Park

All Listed Sponsors

lead

Tarsus Pharmaceuticals, Inc.

INDUSTRY